245 related articles for article (PubMed ID: 16450464)
21. NIH clears most researchers in conflict-of-interest probe.
Weiss R
Washington Post; 2005 Feb; ():A1, A4. PubMed ID: 15742522
[No Abstract] [Full Text] [Related]
22. "Serious misconduct" by NIH expert found: scientist did not report sending tissues to drug firm and getting paid, report says.
Weiss R
Washington Post; 2006 Jun; ():A6. PubMed ID: 16856293
[No Abstract] [Full Text] [Related]
23. A prostate researcher tested firm's product -- and sat on its board.
Burton TM
Wall St J (East Ed); 1998 Mar; ():A1, A8. PubMed ID: 11648093
[No Abstract] [Full Text] [Related]
24. Hailed as a Surgeon General, Koop criticized on web ethics.
Noble HB
N Y Times Web; 1999 Sep; ():1, 20. PubMed ID: 11648137
[No Abstract] [Full Text] [Related]
25. Science on trial: conflicts of interest jeopardize scientific integrity and public health.
Krimsky S
Genewatch; 2003; 16(5):3-6. PubMed ID: 15025119
[No Abstract] [Full Text] [Related]
26. Physician-industry relations--will fewer gifts make a difference?
Steinbrook R
N Engl J Med; 2009 Feb; 360(6):557-9. PubMed ID: 19196671
[No Abstract] [Full Text] [Related]
27. Potential conflicts cited in process for new drugs.
Bakalar N
N Y Times Web; 2005 Oct; ():F7. PubMed ID: 16276613
[No Abstract] [Full Text] [Related]
28. Review cites ethical lapses by scientists.
McNeil DG
N Y Times Web; 2005 Jul; ():A15. PubMed ID: 16060022
[No Abstract] [Full Text] [Related]
29. University physician-researcher conflicts of interest: the inadequacy of current controls and proposed reform.
Maatz CT
High Technol Law J; 1992; 7():137-88. PubMed ID: 11659962
[No Abstract] [Full Text] [Related]
30. Why the data diverge on the dangers of Vioxx: even in medical journals, statistics can be subject to broad interpretation.
Pollack A; Abelson R
N Y Times Web; 2006 May; ():C1, C5. PubMed ID: 16752456
[No Abstract] [Full Text] [Related]
31. Agency scientists divided over ethics ban on consulting.
Harris G
N Y Times Web; 2005 Feb; ():A17. PubMed ID: 15700373
[No Abstract] [Full Text] [Related]
32. Research accountability and financial conflicts of interest in industry-sponsored clinical research: a review.
Tereskerz PM
Account Res; 2003; 10(3):137-58. PubMed ID: 14979317
[No Abstract] [Full Text] [Related]
33. Scientists assail Congress on bill for money to test an AIDS drug.
Meier B
N Y Times Web; 1992 Oct; ():A1, B8. PubMed ID: 11646938
[No Abstract] [Full Text] [Related]
34. FDA issues concerning conflicts of interest.
Kurt TL
IRB; 1990; 12(5):6-9. PubMed ID: 11654003
[No Abstract] [Full Text] [Related]
35. Academics face abuse of rules designed to protect research.
Cowen RC
Christ Sci Monitor; 1998 Mar; ():13. PubMed ID: 11647561
[No Abstract] [Full Text] [Related]
36. Character and the ethical conduct of research.
Pellegrino ED
Account Res; 1992; 2(1):1-11. PubMed ID: 11651456
[No Abstract] [Full Text] [Related]
37. NIH will restrict outside income: tighter rules address concerns about conflicts of interest.
Weiss R
Washington Post; 2005 Feb; ():A1, A7. PubMed ID: 15700372
[No Abstract] [Full Text] [Related]
38. Ten steps to developing a national agenda to address financial conflicts of interest in industry sponsored clinical research.
Tereskerz PM; Moreno J
Account Res; 2005; 12(2):139-55. PubMed ID: 16220626
[TBL] [Abstract][Full Text] [Related]
39. Pharmacists paid to suggest drugs: some doctors dislike a link with the manufacturers.
Kolata G
N Y Times Web; 1994 Jul; ():A1, D2. PubMed ID: 11647034
[No Abstract] [Full Text] [Related]
40. Questions raised of conflicts at 2 hospital buying groups.
Bogdanich W; Meier B; Walsh MW
N Y Times Web; 2002 Mar; ():A1, 18, 19. PubMed ID: 11982000
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
